Rasagiline

Rasagiline is an oral medication used to treat patients with Parkinson’s disease, a progressive neurological disorder that affects movement and coordination. It belongs to a class of drugs called monoamine oxidase-B (MAO-B) inhibitors, which work by inhibiting an enzyme that breaks down dopamine, a neurotransmitter essential for normal motor function.
Rasagiline is prescribed for early-stage Parkinson’s disease to help manage the symptoms such as tremors, stiffness, and difficulty with balance and movement. By increasing dopamine levels in the brain, it helps to improve motor symptoms and slow down the progression of the disease. It is often used as part of a comprehensive treatment plan, which may include other medications, physical therapy, and lifestyle modifications.
It is crucial for patients taking rasagiline to follow their healthcare provider’s instructions carefully. The medication should be taken consistently as prescribed, and patients should not change the dosage without consulting their doctor. Additionally, maintain a healthy diet and avoid certain foods that can interact with rasagiline and increase the risk of serious side effects, such as high blood pressure.
Some common side effects of rasagiline include dizziness, nausea, constipation, and swelling of the legs. However, these side effects are usually mild and may improve over time. Patients should discuss any side effects with their healthcare provider to determine if adjustments to the medication or treatment plan are necessary.